USTEKINUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: RESULTS OF THE PHASE 3, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED PSUMMIT I STUDY

被引：0
|
作者：
McInnes, I. B. [1 ]
Kavanaugh, A. [2 ]
Gottlieb, A. B. [3 ]
Puig, L. [4 ]
Rahman, P. [5 ]
Ritchlin, C. [6 ]
Li, S. [7 ]
Wang, Y. [7 ]
Mendelsohn, A. M. [7 ]
Doyle, M. K. [7 ,8 ]
机构：
[1] U Glasgow, Glasgow, Lanark, Scotland
[2] U Calif, San Diego, CA USA
[3] Tufts Med Cntr, Boston, MA USA
[4] Univ Autonoma Barcelona, E-08193 Barcelona, Spain
[5] Mem U, St John, NF, Canada
[6] U Rochester, Rochester, NY USA
[7] Janssen R&D, Spring House, PA USA
[8] U Penn, Philadelphia, PA USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 71卷
关键词：
D O I：
10.1136/annrheumdis-2012-eular.1841
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：107 / 107
页数：1
相关论文
共 50 条
  • [31] SECUKINUMAB INHIBITS RADIOGRAPHIC PROGRESSION IN PATIENTS WITH PSORIATIC ARTHRITIS: DATA FROM A PHASE 3 RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY (FUTURE 1)
    Van der Heijde, D.
    Landewe, R.
    Mease, P.
    McInnes, I. B.
    Conaghan, P. G.
    Pricop, L.
    Ligozio, G.
    Richards, H.
    Mpofu, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 347 - 348
  • [32] Apremilast in Patients With Active Rheumatoid Arthritis: A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study
    Genovese, Mark C.
    Jarosova, Katerina
    Cieslak, Dorota
    Alper, Jeffrey
    Kivitz, Alan
    Hough, Douglas R.
    Maes, Peter
    Pineda, Lilia
    Chen, Mindy
    Zaidi, Farrukh
    ARTHRITIS & RHEUMATOLOGY, 2015, 67 (07) : 1703 - 1710
  • [33] The effect of guselkumab on inhibiting radiographic progression in patients with active psoriatic arthritis: study protocol for APEX, a Phase 3b, multicenter, randomized, double-blind, placebo-controlled trial
    Ritchlin, Christopher T.
    Coates, Laura C.
    Mease, Philip J.
    van der Heijde, Desiree
    Song, Jiao
    Jiang, Yusang
    Shawi, May
    Kollmeier, Alexa P.
    Rahman, Proton
    TRIALS, 2023, 24 (01)
  • [34] The effect of guselkumab on inhibiting radiographic progression in patients with active psoriatic arthritis: study protocol for APEX, a Phase 3b, multicenter, randomized, double-blind, placebo-controlled trial
    Christopher T. Ritchlin
    Laura C. Coates
    Philip J. Mease
    Désirée van der Heijde
    Jiao Song
    Yusang Jiang
    May Shawi
    Alexa P. Kollmeier
    Proton Rahman
    Trials, 24
  • [35] Maintenance Of Efficacy and Safety Of Ustekinumab In Patients With Active Psoriatic Arthritis Despite Prior Conventional Nonbiologic and Anti-TNF Biologic Therapy: 1-year Results Of a Phase 3, Multicenter, Double-Blind, Placebo-Controlled Trial
    Ritchlin, Christopher T.
    McInnes, Iain B.
    Kavanaugh, Arthur
    Puig, Lluis
    Rahman, Proton
    Brodmerkel, Carrie
    Li, Shu
    Shen, Yaung-Kaung
    Doyle, Mittie K.
    Mendelsohn, Alan M.
    Gottlieb, Alice B.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S127 - S128
  • [36] Secukinumab is effective in reducing dactylitis and enthesitis using multiple measures in patients with psoriatic arthritis: Results of a phase 3 randomized, multicenter, double-blind, placebo-controlled study (FUTURE 2)
    Mease, P.
    Kirkham, B.
    McInnes, I. B.
    Kremer, J.
    Kandala, S.
    Pricop, L.
    Mpofu, S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S30 - S30
  • [37] Secukinumab improves signs and symptoms of active psoriatic arthritis: Results from a phase 3 randomized, multicenter, double-blind, placebo-controlled study using a subcutaneous dosing regimen (FUTURE 2)
    Gottlieb, A. B.
    McInnes, I. B.
    Mease, P.
    Kirkham, B.
    Kavanaugh, A.
    Ligozio, G.
    Pricop, L.
    Mpofu, S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S29 - S29
  • [38] Ustekinumab, an anti-IL-12/23 p40 monoclonal antibody, inhibits radiographic progression in patients with active psoriatic arthritis: results of an integrated analysis of radiographic data from the phase 3, multicentre, randomised, double-blind, placebo-controlled PSUMMIT-1 and PSUMMIT-2 trials
    Kavanaugh, Arthur
    Ritchlin, Christopher
    Rahman, Proton
    Puig, Lluis
    Gottlieb, Alice B.
    Li, Shu
    Wang, Yuhua
    Noonan, Lenore
    Brodmerkel, Carrie
    Song, Michael
    Mendelsohn, Alan M.
    McInnes, Iain B.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (06) : 1000 - 1006
  • [39] Efficacy and safety of ustekinumab in psoriatic arthritis patients with peripheral arthritis and physician-reported spondylitis: post-hoc analyses from two phase III, multicentre, double-blind, placebo-controlled studies (PSUMMIT-1/PSUMMIT-2)
    Kavanaugh, Arthur
    Puig, Lluis
    Gottlieb, Alice B.
    Ritchlin, Christopher
    You, Yin
    Li, Shu
    Song, Michael
    Randazzo, Bruce
    Rahman, Proton
    McInnes, Iain B.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (11) : 1984 - 1988
  • [40] EFFICACY AND SAFETY RESULTS OF GUSELKUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS OVER 56 WEEKS FROM A PHASE 2A, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    Deodhar, A.
    Gottlieb, A. B.
    Boehricke, W-H.
    Dong, B.
    Wang, Y.
    Zhuang, Y.
    Barchuk, W.
    Xu, X. L.
    Hsia, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 201 - 201
12345